Tamar Ringel-Kulka, MD

 
 
 
 
  Research Assistant Professor
Maternal and Child Health

Curriculum Vitae
REACH NC (Collexis) Research Profile

  Rosenau Hall, Room 404A , 421 Pittsboro Street
135 Dauer Drive
Campus Box 7445
Chapel Hill 27599-7445
USA
T: 919-843-1054
F: 919-966-0458

ringelta@email.unc.edu

This email address is being protected from spam bots, you need Javascript enabled to view it

 

 

 
Education
2000 University of North Carolina at Chapel Hill MPH, Health Policy and Administration
1987 Technion-Israel Institute of Technology MD, Medicine
 
 
 
Key publications

Ringel-Kulka T, Cheng J, Rengel Y, et al. (2013)
Intestinal microbiota in healthy U.S. young children and adults – a high throughput microarray analysis.
PLOS ONE: vol. 8(5):e64315.

Jensen ET, Kappelman MD, Ringel-Kulka T, Kim HP, Dellon ES (2013)
Early life exposures as risk factors for pediatric eosinophilic esophagitis: a pilot and feasibility study.
J Pediatr Gastroenterol Nutr: vol. 57(1), p. 67-71.

Carroll IM, Ringel-Kulka T, Ferrier L, Wu M, Siddle JP, Bueno L, Ringel Y (2013)
Fecal protease activity is associated with compositional alterations in the intestinal microbiota.
PLOS ONE: vol. 8(10):e78017.

Ringel-Kulka T (2012)
Targeting the intestinal microbiota in the pediatric population – a clinical perspective..
Nutr Clin Pract: vol.27(2), p.226-234.

Ringel-Kulka T (2012)
Evidence-Base for Probiotic Products for the Pediatric Population..
J Pediatr Gastroenterol Nutr: vol.54(5), p.578-579.

Frantz DJ, Ringel-Kulka T (2012)
Obesity and Eating Disorders. In Gastroenterology and Hepatology, Pearls of Wisdom, JK DiBaise editor.
Boston Medical Publishing, Inc

Ringel-Kulka T, Jensen ET, McLaurin S, Woods E, Bowling M, Kotch J, Labbok M, Dardess P, Baker S. (2011)
Community Based Participatory Research of Breastfeeding Disparities in African American Women.
Infant Child Adolesc Nutr: vol.3(4), p.233-239.

Ringel-Kulka T, Palsson OS, Maier D, Carroll I, Galanko JA, Leyer G, Ringel Y. (2011)
Probiotic bacteria Lactobacillus acidophilus NCFM and Bifidobacterium Lactis Bi-07 versus placebo for the symptoms of bloating in patients with functional bowel disorders.
J Clin Gastroenterol: vol.45(6), p.518-525.